Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Is a | Product containing sulfathiazole (medicinal product) | true | Inferred relationship | Some | ||
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Is a | Product containing sulfacetamide (medicinal product) | true | Inferred relationship | Some | ||
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Is a | Product containing sulfabenzamide (medicinal product) | true | Inferred relationship | Some | ||
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Has active ingredient | Sulfathiazole (substance) | true | Inferred relationship | Some | 3 | |
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Has active ingredient | Sulfabenzamide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Has active ingredient | Sulfacetamide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Is a | Product containing sulfacetamide in vaginal dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Has manufactured dose form | Vaginal dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sulfabenzamide+sulfacetamide+sulfathiazole 3.7%/2.86%/3.42% vaginal cream | Is a | False | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Inferred relationship | Some | |
| Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | False | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Inferred relationship | Some | |
| Sulfabenzamide + sulfacetamide + sulfathiazole 184mg/143.75mg/172.5mg tablet | Is a | False | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Inferred relationship | Some | |
| Sulfabenzamide + sulfacetamide + sulfathiazole 3.7%ww/2.86%ww/3.42%ww cream | Is a | False | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Inferred relationship | Some | |
| Sulfabenzamide and sulfacetamide and sulfathiazole only product | Is a | True | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Inferred relationship | Some | |
| Sulfabenzamide- and sulfacetamide- and sulfathiazole-containing product in vaginal dose form | Is a | True | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | Inferred relationship | Some |
Reference Sets
FHIR